Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
This study underscores the complexity of prescribing antiseizure medications during pregnancy, revealing that while topiramate and lamotrigine show no significant increase in autism spectrum disorder risk post-adjustment, valproate exposure remains a concern due to its association with a higher ASD incidence.
Neurology April 2nd 2024
Pharmacy Learning Network
In the midst of stabilizing adolescent drug use rates, the surge in overdose deaths calls for a nuanced understanding and approach to SUDs among young populations.
Family Medicine/General Practice March 19th 2024
Psych Congress Network
This study offers valuable insights into the safety of stimulant medication use during pregnancy, highlighting the need for nuanced patient counseling and consideration of individual risks and benefits in managing ADHD symptoms.
Neurology March 12th 2024
Johns Hopkins Medicine
Johns Hopkins psychiatrists are spearheading a novel educational initiative, ADAP Jr. High, to address the critical gap in middle schoolers’ understanding of anxiety and depression, offering structured lessons and coping strategies to empower young students.
Family Medicine/General Practice March 12th 2024
Cleveland Clinic Journal of Medicine
The CODA trial illuminates a pivotal moment in appendicitis management, highlighting antibiotics as a noninferior treatment to appendectomy, which could significantly influence patient outcomes and healthcare resource allocation, especially during public health emergencies like the COVID-19 pandemic.
Emergency Medicine March 6th 2024
In a recent clinical trial, omalizumab demonstrated a significant increase in the threshold for allergic reactions to multiple food allergens in children and adolescents, suggesting its potential as a viable treatment option beyond current therapies. This study opens new avenues for the management of food allergies, providing hope for enhanced quality of life for affected individuals.
Allergy & Immunology March 6th 2024